Regkirona
Indonesia • Dexa Medica
Indication
Under the EUA, regdanvimab is indicated for the treatment of confirmed Covid-19 in adult patients that do not require supplemental oxygen and who are at high risk for progressing to severe Covid-19.
Composition
Regdanvimab 60 mg
Package
1 vial of 16 ml
Dosage Forms
Solution for InfusionWarning
Alcohol
Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
Consult Your Doctor
Safety of this item for use while operating heavy machinery has not been established. Please consult your doctor.
Pregnancy
Caution
This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
Lactation
Consult Your Doctor
Safety of this item for use during lactation has not been established. Please consult your doctor.
Dosage
0-17 Years Old
The safety and efficacy of regdanvimab in pediatric patients have not yet been established. No data are available.
18 Years Old and Above
The recommended dosage of regdanvimab is a single intravenous (IV) infusion of 40 mg/kg. Treatment should be initiated as soon as possible after diagnosis, and not later than 7 days after the onset of symptoms.
65 Years Old and Above
No dose adjustment of regdanvimab is required in elderly patients.